Foundation Medicine at the 14th Clinical Biomarkers & Companion Diagnostics Summit Europe

Join us for two exciting networking and learning opportunities:

1. Tuesday, April 23rd, 2 pm – 4 pm: Attend our pre-conference engager on “Advancing Novel Biomarkers from Discovery through Clinical Development” to learn more about:

• Our innovative new biomarkers, like Foundation Medicine's HRD signature and ctDNA tumor fraction
• How your diagnostics partner can support early biomarker discovery efforts through global clinical trial development and regulatory milestones
• This is an invitation only event, if interested please fill out the form below.
• Download more information about our HRD signature and ctDNA tumor fraction.

2. Thursday, April 25th, 10 am – 10:30 am: Varun Pattani, Sr Dir, Diagnostic Development, Clinical & Scientific Operations, will be presenting “Approach IVDR, Global Trials and CDx with Confidence: How the Right Diagnostics Partner Can Make It Possible”

• Learn about Foundation Medicine’s regulatory approach, and how existing platform validation data can accelerate timelines for CDx approval
• Gain insights and expectations on the study start-up process across different countries, such as China and Europe, with a focus on our experience through notification and authorization pathways under IVDR
• Look at what’s ahead, with new biomarkers like HRDsig and ctDNA tumor fraction, as well as possibilities for CDx milestones across RNA, heme malignancies, and real-world data